Literature DB >> 20586946

Chronic kidney disease awareness, screening and prevention: rationale for the design of a public education program.

Allan J Collins1, David T Gilbertson, Jon J Snyder, Shu-Cheng Chen, Robert N Foley.   

Abstract

Design principles for a chronic kidney disease (CKD) screening program start with the general population at increased risk of CKD. Simple risk factor analysis demonstrates diabetes, hypertension, cardiovascular disease and older age as significant associated conditions. More comprehensive risk factor analysis shows only diabetes and hypertension as risk factors in people aged less than 50-60 years, and that anyone aged older than 50-60 years is at risk. Assessment of the relationship between CKD stage and cardiovascular risk factors shows early stage CKD to be associated with poor blood pressure control, which should be addressed. Other risk factors should be more completely assessed to determine if participants and their physicians are adequately addressing factors amenable to treatment to reduce high adverse event rates, premature death and progression to end-stage renal disease (ESRD). Such assessment is needed to reduce the high burden of ESRD on national health-care systems, which can only be addressed by early screening and active treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20586946     DOI: 10.1111/j.1440-1797.2010.01312.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  15 in total

Review 1.  Adipokines protecting CKD.

Authors:  Satoshi Miyamoto; Kumar Sharma
Journal:  Nephrol Dial Transplant       Date:  2013-11       Impact factor: 5.992

2.  Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis.

Authors:  Ki Wung Chung; Poonam Dhillon; Shizheng Huang; Xin Sheng; Rojesh Shrestha; Chengxiang Qiu; Brett A Kaufman; Jihwan Park; Liming Pei; Joseph Baur; Matthew Palmer; Katalin Susztak
Journal:  Cell Metab       Date:  2019-08-29       Impact factor: 27.287

3.  Pilot study of a physician-delivered education tool to increase patient knowledge about CKD.

Authors:  Julie Wright Nunes; Jane H Greene; Kenneth Wallston; Svetlana Eden; Ayumi Shintani; Tom Elasy; Russell L Rothman; T Alp Ikizler; Kerri L Cavanaugh
Journal:  Am J Kidney Dis       Date:  2013-03-27       Impact factor: 8.860

4.  Salutary effects of a novel oxidative stress modulator on adenine-induced chronic progressive tubulointerstitial nephropathy.

Authors:  Susanne B Nicholas; Jun Yuan; Amin Aminzadeh; Keith C Norris; Albert Crum; Nosratola D Vaziri
Journal:  Am J Transl Res       Date:  2012-07-20       Impact factor: 4.060

Review 5.  The story of Notch and chronic kidney disease.

Authors:  Shuchita Sharma; Yasemin Sirin; Katalin Susztak
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-01       Impact factor: 2.894

Review 6.  Socioeconomic disparities in chronic kidney disease.

Authors:  Susanne B Nicholas; Kamyar Kalantar-Zadeh; Keith C Norris
Journal:  Adv Chronic Kidney Dis       Date:  2015-01       Impact factor: 3.620

7.  Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible Mediator.

Authors:  Satoshi Miyamoto; Cheng-Chih Hsu; Gregory Hamm; Manjula Darshi; Maggie Diamond-Stanic; Anne-Emilie Declèves; Larkin Slater; Subramaniam Pennathur; Jonathan Stauber; Pieter C Dorrestein; Kumar Sharma
Journal:  EBioMedicine       Date:  2016-03-28       Impact factor: 8.143

8.  Does a medical management program for CKD patients postpone renal replacement therapy and mortality? A 5-year-cohort study.

Authors:  Mitra Mahdavi-Mazdeh; Zinat Nadia Hatmi; Sara Shahpari-Niri
Journal:  BMC Nephrol       Date:  2012-10-22       Impact factor: 2.388

9.  Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.

Authors:  Francesca Solagna; Caterina Tezze; Maja T Lindenmeyer; Shun Lu; Guochao Wu; Shuya Liu; Yu Zhao; Robert Mitchell; Charlotte Meyer; Saleh Omairi; Temel Kilic; Andrea Paolini; Olli Ritvos; Arja Pasternack; Antonios Matsakas; Dominik Kylies; Julian Schulze Zur Wiesch; Jan-Eric Turner; Nicola Wanner; Viji Nair; Felix Eichinger; Rajasree Menon; Ina V Martin; Barbara M Klinkhammer; Elion Hoxha; Clemens D Cohen; Pierre-Louis Tharaux; Peter Boor; Tammo Ostendorf; Matthias Kretzler; Marco Sandri; Oliver Kretz; Victor G Puelles; Ketan Patel; Tobias B Huber
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 14.808

10.  Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming.

Authors:  Shizheng Huang; Jihwan Park; Chengxiang Qiu; Ki Wung Chung; Szu-Yuan Li; Yasemin Sirin; Seung Hyeok Han; Verdon Taylor; Ursula Zimber-Strobl; Katalin Susztak
Journal:  PLoS Biol       Date:  2018-09-18       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.